| Serial Number | 98084156 |
| Word Mark | EXPLORE44-OLE |
| Filing Date | Thursday, July 13, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 4, 2024 |
| Goods and Services | Antibodies for medical purposes comprising oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders, none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes |
| Pseudo Mark | EXPLORE FOUR FOUR OLE; EXPLORE FORTY FOUR OLE |
| Goods and Services | Medical and scientific research, namely, conducting clinical trials for others for oligonucleotide-based therapeutics in the fields of pharmaceuticals and biotechnology, namely, conducting clinical trials for the treatment of viral diseases and disorders, endocrine diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, neuromuscular diseases and disorders, rare muscle diseases, cardiomyopathies diseases and disorders, heart muscle diseases, muscular dystrophies, muscle atrophy diseases and disorders, genitourinary diseases and disorders, sexual dysfunction, oncological diseases and disorders, hepatological diseases and disorders, ophthalmic diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, dermatological diseases and disorders and psychiatric diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; none of the aforementioned offerings being in the nature of dietetic substances for medical use, foods for special medical purposes, or special nutritional food products for medical purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, August 13, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, August 13, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Avidity Biosciences, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Avidity Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Event Date | Event Description |
| Monday, July 17, 2023 | NEW APPLICATION ENTERED |
| Sunday, August 13, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 23, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, February 23, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, March 26, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 26, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 26, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, April 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 21, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, May 1, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 15, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, April 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |